rts logo

These Numbers Show Favorable Signs for Unicycive Therapeutics Inc (UNCY)

Unicycive Therapeutics Inc (NASDAQ: UNCY) is -56.79% lower on its value in year-to-date trading and has touched a low of $0.20 and a high of $1.82 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The UNCY stock was last observed hovering at around $0.31 in the last trading session, with the day’s gains setting it 0.06%.

Currently trading at $0.37, the stock is -1.55% and -22.35% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 5.36 million and changing 21.33% at the moment leaves the stock -57.04% off its SMA200. UNCY registered -53.32% loss for a year compared to 6-month loss of -72.64%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a -6.27% gain in the last 1 month and extending the period to 3 months gives it a -63.95%, and is 9.08% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 31.95% over the week and 15.20% over the month.

Unicycive Therapeutics Inc (UNCY) has around 14 employees, a market worth around $35.38M and $0.00M in sales. Distance from 52-week low is 85.59% and -79.38% from its 52-week high. The company has generated returns on investments over the last 12 months (-95.94%).

The EPS is expected to grow by 46.76% this year.

Unicycive Therapeutics Inc (UNCY) Top Institutional Holders

27.0 institutions hold shares in Unicycive Therapeutics Inc (UNCY), with institutional investors hold 39.53% of the company’s shares. The shares outstanding are 94.36M, and float is at 83.54M with Short Float at 1.60%. Institutions hold 36.60% of the Float.

The top institutional shareholder in the company is BVF INC/IL with over 3.61 million shares valued at $$4.98 million. The investor’s holdings represent 14.7176 of the UNCY Shares outstanding. As of 2024-03-31, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 3.47 million shares valued at $$4.79 million to account for 14.1434 of the shares outstanding. The other top investors are VIVO CAPITAL, LLC which holds 3.47 million shares representing 14.1412 and valued at over $$4.79 million, while LOGOS GLOBAL MANAGEMENT LP holds 14.1403 of the shares totaling 3.47 million with a market value of $$3.01 million.

Related Posts